Kexing Biopharm Market Cap

Kexing Biopharm has a market cap or net worth of 5.67 billion as of April 29, 2026. Its market cap has increased by 16.67% in one year.

Market Cap

5.67B

Enterprise Value

6.42B

Revenue

1.53B

Ranking

n/a

PE Ratio

36.25

Stock Price

25.89

Market Cap Chart

Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 5.67B, a decrease of -30.37%. That is a compound annual growth rate of -6.52%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	5.67B	-9.57%
Dec 31, 2025	6.27B	45.13%
Dec 31, 2024	4.32B	7.17%
Dec 29, 2023	4.03B	-5.31%
Dec 30, 2022	4.26B	-24.16%
Dec 31, 2021	5.62B	-30.78%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wuhan Hvsen Biotechnology	5.70B
Beijing Konruns Pharmaceutical	5.69B
Shouyao Holdings (Beijing) Co., LTD.	5.79B
Shenzhen Weiguang Biological Products	5.88B
Novogene	5.90B
PharmaResources (Shanghai)	5.90B
Lifecome Biochemistry	5.96B
Hangzhou Biotest Biotech	5.28B

Market Cap Rankings